EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Curative metastasectomy in a patient with colon cancer harboring BRAF V600E mutation and mismatch repair deficiency – a case study.

Natalia Ostruszka, Maria Rozpłoch-Sapa, Patrycja Mrowczyk, Anna Sowa-Staszczak, Piotr Wójcik, Paweł Michał Potocki

Polish Annals of Medicine · 20.05.2026 · 33 · 123-128

DOI: 10.31648/paom/211780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Annals of Medicine, online erschienen am 20.05.2026. Verfasst von Natalia Ostruszka und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Both BRAF V600E mutation and mismatch repair deficiency bear prognostic and predictive relevance in metastatic colorectal cancer, yet impact of simultaneous occurrence of both factors on prognosis is under-investigated.

Aim

Although retrospective studies support localised therapies for oligometastatic CRC in the general population, data for tumours harbouring both alterations are scarce. Case study In 2013, a 66-year-old female underwent radical resection for pT3 N0 distal sigmoid adenocarcinoma. Five months later she was diagnosed with oligometastatic recurrence in the right ovary. In 2014 the woman underwent hysterectomy and bilateral adnexectomy. Histopathology of the resected material confirmed adenocarcinoma metastasis in the right ovary. As the radicality of the resection was uncertain, the patient received 12 cycles of FOLFIRI chemotherapy after which the treatment was suspended due to no evidence of the disease. The follow-up imaging showed no signs of recurrence. A retrospective testing of tumor samples from metastasectomy revealed a BRAF V600E mutation and loss of MLH1, PMS2 expression indicating dMMR. Results and discussion Recently emerging data indicate at better prognosis in metastatic colorectal cancer with coexisting BRAF V600E mutation and dMMR as compared to cases with either of these biomarkers. The literature on the outcomes of metastatic resection in population with both alterations is scarce. The patient described here is an example of favourable outcome, with over 10-year survival after local treatment of colorectal metastases with aforementioned molecular profile.

Conclusions

Metastasis resection, should be further investigated in colorectal cancers harbouring high risk molecular alterations.

Zitieren

APA

Ostruszka, N., Rozpłoch-Sapa, M., Mrowczyk, P., Sowa-Staszczak, A., Wójcik, P., & Potocki, P. M. (2026). Curative metastasectomy in a patient with colon cancer harboring BRAF V600E mutation and mismatch repair deficiency – a case study. Polish Annals of Medicine, 33, 123-128. https://doi.org/10.31648/paom/211780

Vancouver

Ostruszka N, Rozpłoch-Sapa M, Mrowczyk P, Sowa-Staszczak A, Wójcik P, Potocki PM. Curative metastasectomy in a patient with colon cancer harboring BRAF V600E mutation and mismatch repair deficiency – a case study. Polish Annals of Medicine. 2026;33:123-128. doi:10.31648/paom/211780

BibTeX
@article{Ostruszka2026,
  author = {Ostruszka, Natalia and Rozpłoch-Sapa, Maria and Mrowczyk, Patrycja and Sowa-Staszczak, Anna and Wójcik, Piotr and Potocki, Paweł Michał},
  title = {Curative metastasectomy in a patient with colon cancer harboring BRAF V600E mutation and mismatch repair deficiency – a case study},
  journal = {Polish Annals of Medicine},
  year = {2026},
  volume = {33},
  pages = {123--128},
  doi = {10.31648/paom/211780}
}
Kostenlos starten →